Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1159-1169

  Zacny, James P ^a,b   Conley, Kim ^a   Marks, Sandy ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALBUPHINE;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIOSIS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATION DEPRESSION; SELF REPORT; VOMITING;

ADULT; ANALGESICS, OPIOID; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MORPHINE; NALBUPHINE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REFERENCE VALUES;

EID: 0030896583     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, revised, 3rd ed., American Psychiatric Association, Washington DC, 1987.
2. BADDELEY, A. D.: A three-minute reasoning test based on grammatical transformation. Psychonomic Sci. 10: 341-342, 1968.
3. BAHAR, M., ROSEN, M. AND VICKERS, M. D.: Self-administered nalbuphine, morphine and pethidine. Anaesthesia 40: 529-532, 1985.
4. BEAVER, W. T. AND FEISE, G. A.: A comparison of the analgesic effect of intra-muscular nalbuphine and morphine in patients with postoperative pain. J. Pharmacol. Exp. Ther. 204: 487-496, 1978.
5. 3 subtype. J. Pharmacol. Exp. Ther. 251: 461-468, 1989.
6. DEROGATIS, L. R., LIPMAN, R. S. AND COVI, L.: HSCL-90: An outpatient psychiatric rating scale-a preliminary report. Psychopharmacol. Bull. 9: 13-17, 1973.
7. DE SOUZA, E. B., SCHMIDT, W. K. AND KUHAR, M. J.: Nalbuphine: An autoradio-graphic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J. Pharmacol. Exp. Ther. 244: 391-402, 1988.
8. DOLAN, E. A., MURRY, W. J. AND RUDDY, M. P.: Double-blind comparison of nalbuphine and meperidine in combination with diazepam for intravenous conscious sedation in oral surgery outpatients. Oral Surg. Oral Med. Oral Pathol. 66: 536-539, 1988.
9. ELLIOTT, H. W., NAVARRO, G. AND NOMOF, N.: A double blind controlled study of the pharmacological effects of nalbuphine (EN-2234A). J. Med. 1: 74-89, 1970.
10. FEE, J. P., BRADY, M. M., FURNESS, G., CHAMBERS, M. AND CLARKE, R. S.: Analgesia after hip replacement surgery: Comparison of nalbuphine with morphine. Br. J. Anaesth. 63: 756-758, 1989.
11. FRASER, H. F., VAN HORN, G. G., MARTIN, W. R., WOLBACH, A. B. AND ISBELL, H.: Methods for evaluating abuse liability. (A) "Attitude" of opiate addicts towards opiate-like drugs. (B) A short-term "direct" addiction test. J. Pharmacol. Exp. Ther. 133: 371-387, 1961.
12. GAL, T. J., DIFAZIO, C. A. AND MOSCICKL, J.: Analgesic and respiratory depressant activity of nalbuphine: A comparison with morphine. Anesthesiology 57: 367-374, 1982.
13. GERAK, L. R., BUTELMAN, E. R., WOODS, J. H. AND FRANCE, C. P.: Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 271: 993-999, 1994.
14. GERAK, L. R. AND FRANCE, C. P.: Discriminative stimulus effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 276: 523-531, 1995.
15. GRIFFITHS, R. R., TROISI, J. R., SILVERMAN, K. AND MUMFORD, G. K.: Multiple choice procedure: An efficient approach for investigating drug reinforcement in humans. Behav. Pharmacol. 4: 3-13, 1993.
16. HAERTZEN, C. A.: Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol. Rep. 18: 163-194, 1966.
17. HANNINGTON-KIFF, J, G.: Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br. Med. J. 3: 132-135, 1970.
18. HINDMARCH, I.: Psychomotor function and psychoactive drugs. Br. J. Clin. Pharmacol. 10: 189-209, 1980.
19. JAFFE, J. AND MARTIN, W. R.: Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor, pp. 485-521, Pergamon Press, New York: 1990.
20. JASINSKI, D. R. AND MANSKY, P. A.: Evaluation of nalbuphine for abuse potential. Drug Alcohol Depend. 13: 78-90, 1972.
21. MARTIN, W. R.: Opioid antagonists. Pharmacol. Rev. 19: 463-521, 1967.
22. MARTIN, W. R., SLOAN, J. W., SAPIRA, J. D. AND JASINSKI, D. R.: Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12: 245-258, 1971.
23. NUOTTO, E. J. AND KORTTILA, K.: Evaluation of a new computerized psychomotor test battery: Effects of alcohol. Pharmacol. Toxicol. 68: 360-365, 1991.
24. OKUN, R.: Analgesic effects of oral nalbuphine and codeine in patients with postoperative pain. Clin. Pharmacol. Ther. 32: 517-524, 1982.
25. PAIVIO, A., YULLE, J. C. AND MADIGAN S. A.: Concreteness, imagery, and meaningfulness values for 925 nouns. J. Exp. Psychol. 76S: 1-25, 1968.
26. 3 analgesic in mice. J. Pharmacol. Exp. Ther. 262: 1044-1050, 1992.
27. 3 agonists. J. Pharmacol. Exp. Ther. 249: 557-566, 1989.
28. PRESTON, K. L. AND BIGELOW, G. E.: Drug discrimination assessment of agonist-antagonist opioids in humans: A three-choice saline-hydromorphone-butorphanol procedure. J. Pharmacol. Exp. Ther. 271: 48-60, 1994 .
29. PRESTON, K. L., BIGELOW, G. E., BICKEL, W. K. AND LIEBSON, I. A.: Drug discrimination in human postaddicts: Agonist-antagonist opioids. J. Pharmacol. Exp. Ther. 250: 184-196, 1989b.
30. PRESTON, K. L., BIGELOW, G. E. AND LIEBSON, I. A.: Antagonist effects of nalbuphine in opioid-dependent human volunteers. J. Pharmacol. Exp. Ther. 248: 929-937, 1989a.
31. PRESTON, K. L., BIGELOW, G. E. AND LIEBSON, I. A.: Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacol. Biochem. Behav. 37: 511-522, 1990.
32. PRESTON, K. L., LIEBSON, I. A. AND BIGELOW, G. E.: Discrimination of agonistantagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. J. Pharmacol. Exp. Ther. 261: 62-71, 1992.
33. ROMAGNOLI, A. AND KEATS, A. S.: Ceiling effect for respiratory depression by nalbuphine. Clin. Pharmacol. Ther. 27: 478-485, 1980.
34. SAARIALHO-KERE, U.: Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy volunteers. Br. J. Clin. Pharmacol. 26: 79-87, 1988.
35. SHANNON, H. E. AND HOLTZMAN, S. G.: Evaluation of the discriminative stimulus effects of morphine in the rat. J. Pharmacol. Exp. Ther. 198: 54-65, 1976.
36. STEINFELS, G. F., YOUNG, G. A. AND KHAZAN, N.: Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats. Pharmacol. Biochem. Behav. 16: 167-171, 1982.
37. STRAIN, E. C., PRESTON, K. L., LIEBSON I. A. AND BIGELOW, G. E.: Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J. Pharmacol. Exp. Ther. 267: 624-634, 1993.
38. THORNDIKE, E. L. AND LORGE, L.: The teacher's word book of 30,000 words. New York: Columbia University Press; 1944.
39. UNTERWALD, E. M. AND KORNETSKY, C.: Effects of nalbuphine alone and in combination with tripelennamine on rewarding brain stimulation threshold in the rat. Pharmacol. Biochem. Behav. 25: 629-632, 1986.
40. VANACEK, S. A. AND YOUNG, A. M.: Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav. Pharmacol. 6: 669-681, 1995.
41. WALKER, E. A., BUTELMAN, E. R., DE COSTA, B. R. AND WOODS, J. H.: Opioid thermal antinociception in rhesus monkeys: Receptor mechanisms and temperature dependency. J. Pharmacol. Exp. Ther. 267: 280-286, 1993.
42. 2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J. Pharmacol. Exp. Ther. 271: 959-968, 1994.
43. WALKER, E. A. AND YOUNG, A. M.: Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J. Pharmacol. Exp. Ther. 267: 322-330. 1993.
44. WECHSLER, D.: The Measurement and Appraisal of Adult Intelligence. The Williams and Wilkins Co., Baltimore, 1958.
45. YOUNG, A. M., KAPITSOPOULOS, G. AND MAKHAY, M. M.: Tolerance to morphine-like stimulus effects of mu opioid agonists. J. Pharmacol. Exp. Ther. 257: 795-805, 1991.
46. YOUNG, A. M., MASAKI, M. A. AND GEULA, C.: Discriminative stimulus effects of morphine: Effects of training dose on agonist and antagonist effects of mu opioids. J. Pharmacol. Exp. Ther. 261: 246-257, 1984.
47. ZACNY, J. P.: A review of the effects of opiates on psychomotor and cognitive functioning in humans. Exp. Clin. Psychopharm. 3: 432-466, 1995.
48. ZACNY, J. P., LICHTOR, J. L., BINSTOCK, W., COALSON, D. W., CUTTER, T. FLEMMING, D. C. AND GLOSTEN, B.: Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers. Psychopharmacology 111: 306-314, 1993.
49. ZACNY, J. P., LICHTOR, J. L. AND DE WIT, H.: Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers. Anesth. Analg. 74: 523-530, 1992a.
50. ZACNY, J. P., LICHTOR, J. L., FLEMMING, D., COALSON, D. W. AND THOMPSON, W. K.: A dose-response analysis of the subjective, psychomotor, and physiological effects of intravenous morphine in healthy volunteers. J. Pharmacol. Exp. Ther. 268: 1-9, 1994a.
51. ZACNY, J. P., LICHTOR, J. L., KLAFTA, J. M., ALESSI, R. AND APFELBAUM, J. L.: Comparing the effects of transnasal butorphanol to that of intravenous butorphanol and an acetaminophen/codeine drug combination on mood and psychomotor functioning in healthy volunteers. Anesth. Analg. 82: 931-935, 1996.
52. ZACNY, J. P., LICHTOR, J. L., THAPAR, P., COALSON, D. W., FLEMMING, D. AND THOMPSON, W.: Comparing the subjective, psychomotor, and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J. Pharmacol. Exp. Ther. 270: 579-588, 1994b.
53. ZACNY, J. P., LICHTOR, J. L., ZARAGOZA, J. G. AND DE WIT, H.: Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology 107: 319-326, 1992b.